chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Influenza, Vaccination site pain
Clinical narrative: Upper left back pain; Left arm pain; Flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms), VACCINATION SITE PAIN (Left arm pain) and BACK PAIN (Upper left back pain) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, the patient experienced INFLUENZA (Flu symptoms) and VACCINATION SITE PAIN (Left arm pain). On 04-Nov-2021, the patient experienced BACK PAIN (Upper left back pain). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form. At the time of the report, INFLUENZA (Flu symptoms), VACCINATION SITE PAIN (Left arm pain) and BACK PAIN (Upper left back pain) outcome was unknown.            No concomitant medications were reported.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patients were administered vaccines from a vial that has been punctured for greater than 12 hours; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients were administered vaccines from a vial that has been punctured for greater than 12 hours) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A and 939906) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients were administered vaccines from a vial that has been punctured for greater than 12 hours). On 02-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients were administered vaccines from a vial that has been punctured for greater than 12 hours) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment medications reported. No adverse event reported.  It was reported that doses were administered the same vial which was initially punctured on 26-Oct-2021.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Feeling abnormal, Headache, Influenza like illness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced FEELING ABNORMAL (felling bad). On an unknown date, the patient experienced BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Body temperature: 100.6 (High) a temperature 100.6,°F.         No concomitant medication were reported.
Age: 77.0
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced FEELING ABNORMAL (felling bad). On an unknown date, the patient experienced BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felling bad), BONE PAIN (has achy bones), INFLUENZA LIKE ILLNESS (basically they feel like they have the flu), HEADACHE (headaches) and LYMPHADENOPATHY (swollen glands) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2021, Body temperature: 100.6 (High) a temperature 100.6,°F.         No concomitant medication were reported.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax, Deep vein thrombosis, Lung disorder, Peripheral swelling, Pleuritic pain
Clinical narrative: Pt received his 3rd Moderna booster on 11/5/21 after receiving his two prior vaccines on 3/19/21 and 4/16/21. He developed left leg swelling on 11/10/21 which progressed to right sided pleuritic chest pain on 11/11/21. Ultimately he was diagnosed with left lower extremity DVT and right sided pulmonary emboli and right sided pulmonary infarction.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, Pulmonary infarction, Ultrasound Doppler abnormal
Clinical narrative: Pt received his 3rd Moderna booster on 11/5/21 after receiving his two prior vaccines on 3/19/21 and 4/16/21. He developed left leg swelling on 11/10/21 which progressed to right sided pleuritic chest pain on 11/11/21. Ultimately he was diagnosed with left lower extremity DVT and right sided pulmonary emboli and right sided pulmonary infarction.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dizziness, Headache, Hyperhidrosis
Clinical narrative: Dizzy immediately  following shot, continued off and on for several hours, about 10 hours in my chest began to tighten and my rib cage became sore and was painful to take a deep breath. Developed a fever shortly after, chills, sweating, nausea, and headache, inability to sleep.  Still dealing with same issues 5 hours after they started, will call primary care office when they open if symptoms don?t subside.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Insomnia, Musculoskeletal chest pain, Nausea, Pyrexia
Clinical narrative: Dizzy immediately  following shot, continued off and on for several hours, about 10 hours in my chest began to tighten and my rib cage became sore and was painful to take a deep breath. Developed a fever shortly after, chills, sweating, nausea, and headache, inability to sleep.  Still dealing with same issues 5 hours after they started, will call primary care office when they open if symptoms don?t subside.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site discharge, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Vaccination site discharge; Vaccination site lump; Sleep difficult; Vaccination site pruritus; Vaccination site erythema; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.    This case was linked to MOD-2021-376963 (Patient Link).   Reporter did not allow further contact
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Vaccination site discharge; Vaccination site lump; Sleep difficult; Vaccination site pruritus; Vaccination site erythema; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE DISCHARGE (Vaccination site discharge), VACCINATION SITE MASS (Vaccination site lump), INSOMNIA (Sleep difficult), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment medications were not provided by the reporter.    This case was linked to MOD-2021-376963 (Patient Link).   Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration of expired vaccine/ vial was punctured more than 24 hours prior.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine/ vial was punctured more than 24 hours prior.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine/ vial was punctured more than 24 hours prior.). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administration of expired vaccine/ vial was punctured more than 24 hours prior.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was used but not specified by the patient. No treatment drug details was reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Sleep disorder, Tinnitus, Vaccination site pain
Clinical narrative: Ringing in the ears after 2nd dose/Tinnitus after 2nd dose; Can not sleep after 2nd dose; Feels Florescent light over his head after 2nd dose; Sore Arm after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS, SLEEP DISORDER, FEELING ABNORMAL, and VACCINATION SITE PAIN in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Sep-2021, the patient experienced TINNITUS, SLEEP DISORDER, FEELING ABNORMAL, and VACCINATION SITE PAIN. The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, TINNITUS, SLEEP DISORDER, FEELING ABNORMAL, and VACCINATION SITE PAIN outcome was unknown.            No Concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Pyrexia, Somnolence
Clinical narrative: Felt like she was getting the flu; Drowsiness; Headache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like she was getting the flu), SOMNOLENCE (Drowsiness), HEADACHE (Headache), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like she was getting the flu), SOMNOLENCE (Drowsiness), HEADACHE (Headache), PYREXIA (fever) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like she was getting the flu), SOMNOLENCE (Drowsiness), HEADACHE (Headache), PYREXIA (fever) and CHILLS (chills) outcome was unknown.            No concomitant information was reported. No treatment information was reported.   This case was linked to MOD-2021-376999 (Patient Link).
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Hard lump popped up; Hard lump popped up- described as hard, red and painful to touch; Hard lump popped up- described as hard, red and painful to touch; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Hard lump popped up), VACCINATION SITE ERYTHEMA (Hard lump popped up- described as hard, red and painful to touch), VACCINATION SITE PAIN (Hard lump popped up- described as hard, red and painful to touch) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer BIONTECH COVID-19 vaccine (1st and 2nd doses). Past adverse reactions to the above products included No adverse reaction with Pfizer BIONTECH COVID-19 vaccine.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, the patient experienced VACCINATION SITE MASS (Hard lump popped up), VACCINATION SITE ERYTHEMA (Hard lump popped up- described as hard, red and painful to touch), VACCINATION SITE PAIN (Hard lump popped up- described as hard, red and painful to touch) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 05-Nov-2021, VACCINATION SITE MASS (Hard lump popped up) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Hard lump popped up- described as hard, red and painful to touch) and VACCINATION SITE PAIN (Hard lump popped up- described as hard, red and painful to touch) outcome was unknown.            On 05-Nov-2021, a hard lump popped up. It was located in the injection site and was described as hard, red and painful to touch. Patient does not take daily medication and did not take medication to treat symptoms.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown.            No concomitant and treatment medications were reported. The patient had diarrhea.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: Gave a booster dose (0.25ml) to a patient who was eligible for a full 3rd dose (0.5ml) for the immunocompromised; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Gave a booster dose (0.25ml) to a patient who was eligible for a full 3rd dose (0.5ml) for the immunocompromised) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A, 013M20A and 082A21A) for COVID-19 vaccination.     The patient's past medical history included Liver transplant. Concurrent medical conditions included Immunocompromised.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 05-Nov-2021, the patient experienced ACCIDENTAL UNDERDOSE (Gave a booster dose (0.25ml) to a patient who was eligible for a full 3rd dose (0.5ml) for the immunocompromised). On 05-Nov-2021, ACCIDENTAL UNDERDOSE (Gave a booster dose (0.25ml) to a patient who was eligible for a full 3rd dose (0.5ml) for the immunocompromised) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown. Treatment information was unknown.  Patient was eligible for the full 3rd dose (0.5 milliliter) for the immunocompromised due to a history of liver transplant, however, patient received 2.5 milliliter dose. The patient cannot return to the pharmacy until next da, and they want to know how to proceed with completing dose.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Received Full Dose Booster by mistake/Caller received a booster dose of 0.5ml, a full dose.; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 031M20A, and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 05-Nov-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE. On 05-Nov-2021, ACCIDENTAL OVERDOSE had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes on 05-Nov-2021 Follow Up received - Dose 1,2 and 3 date/batch lot no updated.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Thirst, Tongue discomfort
Clinical narrative: Extreme thirst, like nothing before/so thirsty; Tongue stuck to the roof of her mouth; Experienced arm soreness, it went away, then came back intermittently for 5 months; Joint pain in left hip; This spontaneous case was reported by a consumer and describes the occurrence of THIRST (extreme thirst, like nothing before/so thirsty), TONGUE DISCOMFORT (tongue stuck to the roof of her mouth), PAIN IN EXTREMITY (experienced arm soreness, it went away, then came back intermittently for 5 months) and ARTHRALGIA (joint pain in left hip) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 037K20A) for COVID-19 vaccination.     The patient's past medical history included Joint pain (experienced this problem 20 years old ago, the joint pain, but the pain went away when she reduced her salt intake.).   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THIRST (extreme thirst, like nothing before/so thirsty), TONGUE DISCOMFORT (tongue stuck to the roof of her mouth), PAIN IN EXTREMITY (experienced arm soreness, it went away, then came back intermittently for 5 months) and ARTHRALGIA (joint pain in left hip). At the time of the report, THIRST (extreme thirst, like nothing before/so thirsty) and TONGUE DISCOMFORT (tongue stuck to the roof of her mouth) outcome was unknown and PAIN IN EXTREMITY (experienced arm soreness, it went away, then came back intermittently for 5 months) and ARTHRALGIA (joint pain in left hip) had resolved.            No concomitant product was provided by the reporter. No treatment medication was provided.   This case was linked to MOD-2021-377070 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Headache, Myalgia, Pyrexia
Clinical narrative: administered past published expiry; fever; headache; body ache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered past published expiry), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered past published expiry), PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered past published expiry) had resolved and PYREXIA (fever), HEADACHE (headache) and MYALGIA (body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   treatment medications were not reported no concomitant medications were reported
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Limb discomfort, Paraesthesia
Clinical narrative: some fatigue; some chills; arm got red and prickly and super itchy; arm Very itchy and prickly after booster; covid arm (left arm) after booster dose; itchy prickly rash 2 inches lower than the injection site; arm started itchin/super itchy/ Very itchy after booster; had a little discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm (left arm) after booster dose), RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site), PRURITUS (arm started itchin/super itchy/ Very itchy after booster), LIMB DISCOMFORT (had a little discomfort) and ERYTHEMA (arm got red and prickly and super itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A, 023M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included RIVAROXABAN (XARELTO), METFORMIN, METOPROLOL SUCCINATE and LEVOTHYROXINE for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced PRURITUS (arm started itchin/super itchy/ Very itchy after booster) and LIMB DISCOMFORT (had a little discomfort). On 05-Nov-2021, the patient experienced VACCINATION SITE REACTION (covid arm (left arm) after booster dose), RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site), ERYTHEMA (arm got red and prickly and super itchy) and PARAESTHESIA (arm Very itchy and prickly after booster). On an unknown date, the patient experienced FATIGUE (some fatigue) and CHILLS (some chills). At the time of the report, VACCINATION SITE REACTION (covid arm (left arm) after booster dose), PRURITUS (arm started itchin/super itchy/ Very itchy after booster), LIMB DISCOMFORT (had a little discomfort), ERYTHEMA (arm got red and prickly and super itchy), PARAESTHESIA (arm Very itchy and prickly after booster), FATIGUE (some fatigue) and CHILLS (some chills) outcome was unknown and RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site) had not resolved.            No treatment were reported.   This case was linked to MOD-2021-377069 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Nov-2021: Follow up document received included newevent added and outcome of event rash updated.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash pruritic, Vaccination site reaction
Clinical narrative: some fatigue; some chills; arm got red and prickly and super itchy; arm Very itchy and prickly after booster; covid arm (left arm) after booster dose; itchy prickly rash 2 inches lower than the injection site; arm started itchin/super itchy/ Very itchy after booster; had a little discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (covid arm (left arm) after booster dose), RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site), PRURITUS (arm started itchin/super itchy/ Very itchy after booster), LIMB DISCOMFORT (had a little discomfort) and ERYTHEMA (arm got red and prickly and super itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062E21A, 023M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included RIVAROXABAN (XARELTO), METFORMIN, METOPROLOL SUCCINATE and LEVOTHYROXINE for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced PRURITUS (arm started itchin/super itchy/ Very itchy after booster) and LIMB DISCOMFORT (had a little discomfort). On 05-Nov-2021, the patient experienced VACCINATION SITE REACTION (covid arm (left arm) after booster dose), RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site), ERYTHEMA (arm got red and prickly and super itchy) and PARAESTHESIA (arm Very itchy and prickly after booster). On an unknown date, the patient experienced FATIGUE (some fatigue) and CHILLS (some chills). At the time of the report, VACCINATION SITE REACTION (covid arm (left arm) after booster dose), PRURITUS (arm started itchin/super itchy/ Very itchy after booster), LIMB DISCOMFORT (had a little discomfort), ERYTHEMA (arm got red and prickly and super itchy), PARAESTHESIA (arm Very itchy and prickly after booster), FATIGUE (some fatigue) and CHILLS (some chills) outcome was unknown and RASH PRURITIC (itchy prickly rash 2 inches lower than the injection site) had not resolved.            No treatment were reported.   This case was linked to MOD-2021-377069 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Nov-2021: Follow up document received included newevent added and outcome of event rash updated.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My arm is hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (My arm is hurting) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039F21A, 031L20A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, the patient experienced PAIN IN EXTREMITY (My arm is hurting). At the time of the report, PAIN IN EXTREMITY (My arm is hurting) had not resolved.            Concomitant medications were not reported.  treatment medications were not reported    This case was linked to MOD-2021-377030, MOD-2021-377003 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: achiness; little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN and VACCINATION SITE PAIN in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESTRADIOL, MULTIVITAMINUM, VITAMIN D, FISH OIL, METOPROLOL, and MAGNESIUM for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN and VACCINATION SITE PAIN. At the time of the report, PAIN and VACCINATION SITE PAIN outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.       No treatment medications were reported.   This case was linked to MOD-2021-377059, MOD-2021-377060 (Patient Link).
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph nodes on the left side of his neck were swollen/ as big as a grape fruit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph nodes on the left side of his neck were swollen/ as big as a grape fruit) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 032A21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021 at 8:40 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (Lymph nodes on the left side of his neck were swollen/ as big as a grape fruit). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 06-Nov-2021, LYMPHADENOPATHY (Lymph nodes on the left side of his neck were swollen/ as big as a grape fruit) had resolved.            No concomitants medicines were reported.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Arm is still a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is still a little swollen) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 019B21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is still a little swollen). At the time of the report, PERIPHERAL SWELLING (Arm is still a little swollen) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information was not provided. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling cold, Hyperhidrosis, Insomnia, Myalgia
Clinical narrative: Felt her heart was racing; Felt dizzy; Cold to the bone; Started to sweat; Could not sleep; A little pain in the arm; Went to bed achy and thought her meninges were inflamed everywhere; This spontaneous case was reported by a nurse and describes the occurrence of PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat) and INSOMNIA (Could not sleep) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat), INSOMNIA (Could not sleep), PAIN IN EXTREMITY (A little pain in the arm) and MYALGIA (Went to bed achy and thought her meninges were inflamed everywhere). At the time of the report, PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat), INSOMNIA (Could not sleep), PAIN IN EXTREMITY (A little pain in the arm) and MYALGIA (Went to bed achy and thought her meninges were inflamed everywhere) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-377121, MOD-2021-377122 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Palpitations
Clinical narrative: Felt her heart was racing; Felt dizzy; Cold to the bone; Started to sweat; Could not sleep; A little pain in the arm; Went to bed achy and thought her meninges were inflamed everywhere; This spontaneous case was reported by a nurse and describes the occurrence of PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat) and INSOMNIA (Could not sleep) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat), INSOMNIA (Could not sleep), PAIN IN EXTREMITY (A little pain in the arm) and MYALGIA (Went to bed achy and thought her meninges were inflamed everywhere). At the time of the report, PALPITATIONS (Felt her heart was racing), DIZZINESS (Felt dizzy), FEELING COLD (Cold to the bone), HYPERHIDROSIS (Started to sweat), INSOMNIA (Could not sleep), PAIN IN EXTREMITY (A little pain in the arm) and MYALGIA (Went to bed achy and thought her meninges were inflamed everywhere) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were reported.   This case was linked to MOD-2021-377121, MOD-2021-377122 (Patient Link).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia
Clinical narrative: chills; low-grade fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PYREXIA (low-grade fever) and MYALGIA (body aches) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The medical history was not provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR) and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, AMLODIPINE for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced CHILLS (chills), PYREXIA (low-grade fever) and MYALGIA (body aches). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 06-Nov-2021, CHILLS (chills), PYREXIA (low-grade fever) and MYALGIA (body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2021, Body temperature: 99 (Low) low grade fever 99 F.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired doses administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired doses administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by a healthcare professional, describes the occurrence of administered expired product (expired doses administered to patients) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 041C21A) for COVID-19 immunization. No medical history reported. On Nov 5, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Nov 5, 2021, patient administered expired product (expired doses administered to patients). On Nov 5, 2021, administered expired product (expired doses administered to patients) resolved. The reporter did not provide any causality assessments, concomitant medication or treatment information.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Headache, Myalgia, Pain, Vaccination site rash
Clinical narrative: rash underneath the injection site; cold but not as cold as after the 1st dose; more sore; Headache; Body ache; This spontaneous case was reported by a nurse and describes the occurrence of FEELING COLD (cold but not as cold as after the 1st dose), PAIN (more sore), VACCINATION SITE RASH (rash underneath the injection site), HEADACHE (Headache) and MYALGIA (Body ache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 02-Mar-2021, the patient experienced FEELING COLD (cold but not as cold as after the 1st dose) and PAIN (more sore). On 04-Mar-2021, the patient experienced VACCINATION SITE RASH (rash underneath the injection site). In March 2021, the patient experienced HEADACHE (Headache) and MYALGIA (Body ache). In 2021, VACCINATION SITE RASH (rash underneath the injection site) had resolved. At the time of the report, FEELING COLD (cold but not as cold as after the 1st dose), PAIN (more sore), HEADACHE (Headache) and MYALGIA (Body ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported. The night (02-Mar-2021), patient was cold but not as cold as after the 1st dose was able to go to sleep but felt more sore. The patient had a rash underneath the injection site 2 days after and that lasted for a week. The patient also had a headache and body ache.   This case was linked to MOD-2021-377089, MOD-2021-377122 (Patient Link).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lymphoedema, Nasopharyngitis, Pain in extremity, Tenderness
Clinical narrative: This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY, NASOPHARYNGITIS, DIZZINESS, TENDERNESS, and LYMPHOEDEMA in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Nov-2021, the patient experienced PAIN IN EXTREMITY, NASOPHARYNGITIS, and DIZZINESS. On 04-Nov-2021, the patient experienced TENDERNESS and LYMPHOEDEMA. At the time of the report, PAIN IN EXTREMITY, NASOPHARYNGITIS, DIZZINESS, TENDERNESS, and LYMPHOEDEMA outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided   This case was linked to MOD-2021-377121, MOD-2021-377089 (Patient Link).
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Really sick after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Really sick after the second dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 012M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pertussis shot (Bad reaction when a child). Concurrent medical conditions included Drug allergy (Many medication). Concomitant products included GABAPENTIN, PROBIOTICS NOS and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced ILLNESS (Really sick after the second dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of 1 dosage form. At the time of the report, ILLNESS (Really sick after the second dose) outcome was unknown.            Other concomitant medicine include allergy pills.   This case was linked to MOD-2021-377080 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: stiff neck; 2-3 days after second dose, aching; pain at the base of my skull; radiated out to my shoulders; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), MYALGIA (2-3 days after second dose, aching), HEADACHE (pain at the base of my skull) and ARTHRALGIA (radiated out to my shoulders) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), MYALGIA (2-3 days after second dose, aching), HEADACHE (pain at the base of my skull) and ARTHRALGIA (radiated out to my shoulders). At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), MYALGIA (2-3 days after second dose, aching), HEADACHE (pain at the base of my skull) and ARTHRALGIA (radiated out to my shoulders) had resolved.            No treatment medication was reported. No Concomitant medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-377139 (E2B Linked Report). This case was linked to MOD-2021-377123 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-377139:Dose 3 case